Product
Help
Pricing
About
Jobs
Log in
Get started
Keyword
Add to collection
WEB 2086
Description:
WEB 2086, also called apafant, is a pharmacological compound that blocks platelet-activating factor and has been studied as a therapeutic antagonist.
Related topics:
Asthma and respiratory diseases (14%),
Platelet Disorders and Treatments (7%)
Wikidata ID:
wiki/Q27074478
OpenAlex ID:
keywords/web-2086
Pharmacological actions of WEB 2086, a new specific antagonist of platelet activating factor.
1987
·
J Casals-Stenzel
, G Muacevic
, et al.
·
Journal of Pharmacology and Experimental Therapeutics
·
290
Role of platelet-activating factor in ischemia/reperfusion-induced leukocyte adherence
1990
·
P. Kubes
, G. Ibbotson
, et al.
·
American Journal of Physiology-Gastrointestinal and Liver Physiology
·
280
Neutrophil migration across monolayers of cytokine-prestimulated endothelial cells: a role for platelet-activating factor and IL-8.
1992
·
T W Kuijpers
, B C Hakkert
, et al.
·
The Journal of Cell Biology
·
225
PDF
Eosinophil Recruitment into Guinea Pig Lungs after PAF-acether and Allergen Administration: Modulation by Prostacyclin, Platelet Depletion, and Selective Antagonists
1988
·
Arielle Lellouch-Tubiana
, Jean Lefort
, et al.
·
American Review of Respiratory Disease
·
198
Stimulation of degranulation from human eosinophils by platelet-activating factor.
1989
·
C Kroegel
, T Yukawa
, et al.
·
The Journal of Immunology
·
195
Characterization of a human cDNA that encodes a functional receptor for platelet activating factor
1991
·
Richard D. Ye
, Eric R. Prossnitz
, et al.
·
Biochemical and Biophysical Research Communications
·
187
Evidence That Phospholipid Oxidation Products and/or Platelet-Activating Factor Play an Important Role in Early Atherogenesis: In Vitro and In Vivo Inhibition by WEB 2086
1999
·
Ganesamoorthy Subbanagounder
, Norbert Leitinger
, et al.
·
Circulation Research
·
146
Platelet-activating factor contributes to the induction of nitric oxide synthase by bacterial lipopolysaccharide.
1993
·
C Szabó
, C C Wu
, et al.
·
Circulation Research
·
144
Platelet-activating factor may act as a second messenger in the release of icosanoids and superoxide anions from leukocytes and endothelial cells.
1990
·
A G Stewart
, P N Dubbin
, et al.
·
Proceedings of the National Academy of Sciences
·
139
Mechanisms of pulmonary edema induced by tumor necrosis factor-alpha.
1990
·
D C Hocking
, P G Phillips
, et al.
·
Circulation Research
·
124
PDF
Effects of endothelin‐1 on vascular permeability in the conscious rat: interactions with platelet‐activating factor
1991
·
János G. Filep
, Martin G. Sirois
, et al.
·
British Journal of Pharmacology
·
117
Pharmacologic activity of bepafant (WEB 2170), a new and selective hetrazepinoic antagonist of platelet activating factor.
1990
·
H O Heuer
, J Casals-Stenzel
, et al.
·
Journal of Pharmacology and Experimental Therapeutics
·
115
Hypoxia causes ischemic bowel necrosis in rats: The role of platelet-activating factor (PAF-acether)
1990
·
Michael S. Caplan
, Xiao-Ming Sun
, et al.
·
Gastroenterology
·
114
Protective effect of WEB 2086, a novel antagonist of platelet activating factor, in endotoxin shock
1987
·
Jorge Casals-Stenzel
·
European Journal of Pharmacology
·
111
Mechanosensitive Properties of Gastric Vagal Afferent Fibers in the Rat
1999
·
Noriyuki Ozaki
, J. N. Sengupta
, et al.
·
Journal of Neurophysiology
·
103
The Platelet-Activating Factor Receptor Antagonist WEB 2170 Prevents Neonatal Necrotizing Enterocolitis in Rats
1997
·
Michael S. Caplan
, Erik Hedlund
, et al.
·
Journal of Pediatric Gastroenterology and Nutrition
·
98
The Effects of Activated Eosinophils and Neutrophils on Guinea Pig Airway Epithelium In Vitro
1990
·
Tatsuo Yukawa
, Robert C. Read
, et al.
·
American Journal of Respiratory Cell and Molecular Biology
·
96
The Effect of the Orally Active Platelet-Activating Factor Antagonist WEB 2086 in the Treatment of Asthma
1994
·
D P Spence
, S L Johnston
, et al.
·
American Journal of Respiratory and Critical Care Medicine
·
95
Mouse and Human Eosinophils Degranulate in Response to Platelet-Activating Factor (PAF) and LysoPAF via a PAF-Receptor–Independent Mechanism: Evidence for a Novel Receptor
2010
·
Kimberly D Dyer
, Caroline M Percopo
, et al.
·
The Journal of Immunology
·
93
In Vivo Visualization of Reactive Oxidants and Leukocyte-Endothelial Adherence Following Hemorrhagic Shock
2002
·
Ed W. Childs
, Kahdi F. Udobi
, et al.
·
Shock
·
84
Platelet-activating Factor Stimulates Transcription of the Heparin-binding Epidermal Growth Factor-like Growth Factor in Monocytes
1995
·
Zhixing Pan
, Vladimir V. Kravchenko
, et al.
·
Journal of Biological Chemistry
·
84
PDF
Beneficial effects of TCV-309, a novel potent and selective platelet activating factor antagonist in endotoxin and anaphylactic shock in rodents.
1992
·
Z Terashita
, M Kawamura
, et al.
·
Journal of Pharmacology and Experimental Therapeutics
·
82
Endotoxin and Hypoxia-Induced Intestinal Necrosis in Rats: The Role of Platelet Activating Factor
1992
·
Michael S Caplan
, Anne Kelly
, et al.
·
Pediatric Research
·
81
Platelet-activating factor induces eosinophil peroxidase release from purified human eosinophils.
1988
·
C Kroegel
, T Yukawa
, et al.
·
PubMed
·
81
Effect of a platelet activating factor antagonist, WEB 2086, on allergen induced asthmatic responses.
1993
·
A Freitag
, R M Watson
, et al.
·
Thorax
·
79
PDF
Show more works
View as search
Works count:
527
Citation count:
11,840
Year
Topic
Type